Weight-Loss Compound for Gut Microbiota Ratio Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for overweight and obesity, such as exercise, calorie-controlled diets, and medications, are often unsustainable and have adverse side effects, while surgical procedures are costly and uncertain, necessitating a safer and more effective alternative.
Innovation Solution
A compound with the structure of Formula (I), such as Monascinol, is developed to enhance Bacteroidales abundance and reduce the Firmicutes to Bacteroidetes ratio in the gut microbiota, formulated into compositions for weight loss and gut microbiota improvement, using chemical synthesis or Monascus pilosus fermentation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current obesity treatments (exercise, calorie-controlled diet, medications) are used, then weight loss can be achieved, but they are unsustainable and have adverse side effects
Solution Approach 1:
The patent introduces a novel compound as an intermediary substance that mediates between the body's metabolism and gut microbiota. This compound selectively modulates bacterial communities in the gut, acting as a bridge to achieve weight loss through microbial regulation rather than direct metabolic intervention, thereby avoiding harsh side effects while maintaining effectiveness
Solution Approach 2:
The invention changes the parameter of gut microbiota composition by selectively enhancing Bacteroidales abundance and reducing Firmicutes to Bacteroidetes ratio. This parameter change in the microbial ecosystem creates a metabolic environment that promotes fat oxidation and energy expenditure, achieving weight loss through biological parameter modification rather than caloric restriction or stimulant effects
2Reliability
If surgical procedures (liposuction, gastrectomy, gastric bypass) are used for weight loss, then significant weight reduction can be achieved, but costs increase and procedural uncertainty arises
Solution Approach 1:
The patent employs a small-molecule compound that can be administered in manageable doses rather than requiring expensive, irreversible surgical intervention. The compound acts as a temporary, reversible agent that achieves weight loss effects without the permanent structural changes and high costs associated with surgical procedures, making treatment more accessible and financially sustainable
Solution Approach 2:
The compound enables the body's own gut microbiota to perform the weight loss function by selectively modulating bacterial communities. Instead of external surgical intervention, the treatment harnesses the body's existing biological systems (gut bacteria) to achieve the therapeutic effect, reducing reliance on expensive medical infrastructure and procedures
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound effectively aids weight loss and improves gut microbiota composition without adverse effects, promoting health and preventing diseases in overweight or obese populations.
Implementation Method 1
using chemical synthesis or Monascus pilosus fermentation
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a compound of Formula (I), which can be used to prepare a composition for losing weight and improving gut microbiota composition. The invention also provides a composition comprising an effective amount of the compound, which has the ability to increase the abundance of Bacteroidales, thereby reducing the ratio of Firmicutes to Bacteroidetes, and can increase the abundance of beneficial gut bacteria and change the gut microbiota composition. The compound and composition of the invention can be applied in food, medicine, feed, nutritional supplements and other uses.